| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $88.9M | -0.5% | +0.5% |
| Cost of Revenue | $52.8M | -0.6% | +1.5% |
| R&D Expense | $7.2M | -7.9% | -1.2% |
| SG&A Expense | $12.1M | -6.4% | +8.4% |
| Operating Income | $1.7M | +201.4% | +102.9% |
| Pre-tax Income | $142K | +102.0% | +100.2% |
| Income Tax | -$311K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $26.7M | +2.7% | +33.6% |
| Accounts Receivable | $50.6M | -7.1% | -8.3% |
| Current Assets | $91.5M | -5.1% | +7.8% |
| Total Assets | $406.9M | -2.1% | -1.3% |
| Current Liabilities | $141.6M | +1.3% | -1.8% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $19.5M | — | — |
| Capital Expenditures | $649K | — | — |
| Investing Cash Flow | -$17.4M | — | — |
| Financing Cash Flow | -$6.5M | — | — |
| Free Cash Flow | $18.8M | — | — |
| -112.7% |
| +80.8% |
| Net Income | $453K | +104.8% | +100.7% |
| EPS (Basic) | -$0.86 | +68.5% | +93.3% |
| EPS (Diluted) | -$0.86 | +68.5% | +93.3% |
| $41.4M |
| +0.2% |
| — |
| Total Liabilities | $225.7M | -1.9% | +8.7% |
| Stockholders' Equity | -$26.3M | -21.2% | -859.7% |